Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Presse Medicale (Paris, France : 1983)|September 23, 1995
[Invasive group A streptococcal infections in France]M Robain, S Baron, V Goulet
Presse Medicale (Paris, France : 1983)|October 13, 1998
[Prevalence and incidence of cytomegalovirus infection in patients infected with HIV-1. SEROCO group]M Robain, N Carré, D Salmon-Ceron, et al.
Sexually Transmitted Diseases|November 4, 1998
Incidence and sexual risk factors of cytomegalovirus seroconversion in HIV-infected subjects. The SEROCO Study GroupM Robain, N Carré, E Dussaix, et al.
Epidemiology and Infection|December 16, 2000
Is cytomegalovirus infection a co-factor in HIV-1 disease progression?M Robain, F Boufassa, J B Hubert, et al.
AIDS (London, England)|February 24, 2001
Cytomegalovirus seroconversion as a cofactor for progression to AIDSM Robain, F Boufassa, J B Hubert, et al.
AIDS (London, England)|April 19, 2000
Sexual behavior changes and protease inhibitor therapy. SEROCO Study GroupM Miller, L Meyer, F Boufassa, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancerM Robain, J Y Pierga, M Jouve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patientsJ Y Pierga, M Robain, M Jouve, et al.
Pageof 2